Medications

First biosimilar approved to treat multiple sclerosis

The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.

Medications

FDA says ADHD med Adderall is in short supply

People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.

Medications

Study finds 1 in 16 women take harmful drugs during pregnancy

In a review of more than 3 million pregnancies, University of Florida researchers found 1 in 16 women were exposed to harmful teratogenic drugs—medications that can cause pregnancy loss, birth defects and other health problems ...

Neuroscience

A prescription for exercise

Richard Carpenter, 75, was going through the mail one day last year when he saw a postcard from UCI seeking participants for a study on whether exercise can help with age-related memory loss.

Neuroscience

A prescription for exercise

Richard Carpenter, 75, was going through the mail one day last year when he saw a postcard from UCI seeking participants for a study on whether exercise can help with age-related memory loss.

Oncology & Cancer

Benlysta approved for children with lupus

(HealthDay)—The intravenous drug Benlysta (belimumab) has been approved by the U.S. Food and Drug Administration to treat children with lupus, a chronic disease that triggers inflammation and damages tissues and organs ...

page 1 from 6